Cargando…

Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination

BACKGROUND: Public health measures to stem the coronavirus disease 2019 (COVID-19) pandemic are challenged by social, economic, health status, and cultural disparities that facilitate disease transmission and amplify its severity. Prior pre-clinical biomedical technologic advances in nucleic acid-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Monte, Suzanne M, Long, Christine, Szczepanski, Nicole, Griffin, Christopher, Fitzgerald, Amanda, Chapin, Kimberle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504644/ https://www.ncbi.nlm.nih.gov/pubmed/34647020 http://dx.doi.org/10.1177/2632010X211049255

Ejemplares similares

285. Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
por: Chapin, Kimberle, et al.
Publicado: (2020)

A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures
por: Tansarli, Giannoula S., et al.
Publicado: (2022)

mRNA Vaccines Induce Rapid Antibody Responses in Mice
por: Gebre, Makda S., et al.
Publicado: (2021)

mRNA vaccines induce rapid antibody responses in mice
por: Gebre, Makda S., et al.
Publicado: (2022)

Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans
por: Moyles, Iain R., et al.
Publicado: (2023)

Comprehensive antibody profiling of mRNA vaccination in children
por: Bartsch, Yannic C, et al.
Publicado: (2022)

Heterogenous antibody and T‐cell responses to SARS‐CoV‐2 mRNA vaccines among immunocompromised young people
por: Lu, Liangjian, et al.
Publicado: (2023)

From mRNA sensing to vaccines
por: Fauci, Anthony S., et al.
Publicado: (2021)

Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
por: Roeder, Alexa J., et al.
Publicado: (2022)

Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population
por: Sereejav, Enkhbold, et al.
Publicado: (2023)

Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination
por: Hernández-Luis, Pablo, et al.
Publicado: (2022)

Cystic neutrophilic granulomatous mastitis with corynebacterium and staphylococcus mimicking breast carcinoma
por: Wang, Yihong, et al.
Publicado: (2018)

Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination
por: Goel, Rishi R., et al.
Publicado: (2021)

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
por: Ehmsen, Sidse, et al.
Publicado: (2021)

Longitudinal waning of mRNA vaccine-induced neutralizing antibodies against SARS-CoV-2 detected by an LFIA rapid test
por: Wang, Qiao, et al.
Publicado: (2022)

Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy
por: Mencoboni, Manlio, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

From lipids to lipid nanoparticles to mRNA vaccines
por: Horejs, Christine
Publicado: (2021)

Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine
por: Rouvinski, Alexander, et al.
Publicado: (2023)

Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects
por: Wheeler, Sarah E., et al.
Publicado: (2021)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests
por: Kanji, Jamil N., et al.
Publicado: (2021)

Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy
por: Prahl, Mary, et al.
Publicado: (2022)

Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination
por: Ehmsen, Sidse, et al.
Publicado: (2022)

Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
por: Fatima, Zainab, et al.
Publicado: (2022)

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines
por: Abraham, Natalia, et al.
Publicado: (2022)

Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
por: Zhou, Zhao-Hua, et al.
Publicado: (2023)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyads
por: Golan, Yarden, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads
por: Golan, Yarden, et al.
Publicado: (2021)

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
por: Ehmsen, Sidse, et al.
Publicado: (2022)

mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
por: Zhang, Biyan, et al.
Publicado: (2022)

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
por: Liu, Shaojun, et al.
Publicado: (2023)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
por: Ketas, Thomas J., et al.
Publicado: (2021)

Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients
por: Paal, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_as8fh90kl9lsq5qqft7j57p0pr